Skip to main content

抗真菌薬市場 to Reach $17.72 Billion by 2023 at 3.7% CAGR

According to the report, the global Antifungal Drugs market generated $14.23 billion in 2017 and is estimated to reach $17.72 billion by 2023, growing at a CAGR of 3.7% from 2017 to 2023. The report offers a detailed analysis of the key segments, top investment pockets, changing dynamics, market size & estimations, and competitive scenario.

Favorable government funds to combat the antifungal diseases along with the increasing prevalence of fungal infection drive the growth of the market. Furthermore, rising awareness levels pertaining to myriad fungal infections supplement the market growth. However, the growing population with antifungal drug resistance and the presence of counterfeit drugs and side effects of antifungal drugs restrict the growth. On the other hand, patent expirations and increasing funding from public & private organizations offer lucrative opportunities for the market.

Request Report Sample at: https://www.alliedmarketresearch.com/request-sample/2370

Based on drug types, the Azoles segment accounted for nearly two-fifths of the total market share in 2017 and is expected to maintain its dominance by 2023. Furthermore, this segment is estimated to project the fastest CAGR of 4.1% from 2017 to 2023.

Based on dosage form, the drugs segment held nearly one-third of the total market share in 2017 and will maintain its dominance throughout the forecast period. Furthermore, this segment is estimated to register the highest growth rate with a CAGR of 4.2% from 2017 to 2023.


Based on the region, Asia-Pacific would grow at the fastest CAGR of 4.5% from 2017 to 2023. However, the North America region contributed more than one-third of the total share in 2017 and is estimated to maintain its dominance during the forecast period. The report also includes the study of different regions such as Europe and LAMEA.

Based on therapeutic indication, Candidiasis segment held more than one-third of the total market share in 2017 and will maintain its dominance throughout the forecast period. However, the Dermatophytosis segment is estimated to register the highest growth rate with a CAGR of 4.1% from 2017 to 2023.

Do Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/2370

The leading market players analyzed in the research include the GlaxoSmithKline Plc. Pfizer Inc., Enzon Pharmaceuticals, Inc., Sanofi S.A., Scynexis Inc., Gilead Sciences, Inc., Bayer AG, Merck & Co., Inc., Abbott Laboratories, and Novartis International AG. They have adopted different strategies such as mergers & acquisitions, partnerships, collaborations, new product launches, and others to gain a strong position in the global industry.

Comments

Popular posts from this blog

電子健康記録(EHR)市場 ガーナーへ $33.29 Bn, グローバルに, で 5.0% CAGR

T he global   Electronic Health Records (EHR) Market   generated $24.90 billion in 2017, and is expected to generate $33.29 billion by 2023, registering a CAGR of 5.0% from 2017 to 2023. The report offers a detailed analysis of drivers & opportunities, market size & estimations, top winning strategies, key segments, and competitive scenario. Increase in acceptance of cloud-based EHR software worldwide, surge in incidence of chronic diseases, and rise in ageing population drive the growth of the global EHR market. However, expensive EHR software and rise in concerns regarding data security & safety hinder the growth of the industry. On the other hand, untapped potential in emerging countries create lucrative opportunities in the future. Download Sample Report at:   https://www.alliedmarketresearch.com/request-sample/4542 Based on product, the cloud-based software segment is expected to register the highest CAGR of 5.3% from 2017 to 2023, owing to the less upfront costs and l

ライフサイエンス試薬市場、トレンド、分析、機会、シェア、2019-2027年までの予測

  " Life Science Reagents Market research report delivers a comprehensive study on production capacity, consumption, import and export for all major regions across the world. Report provides is a professional inclusive study on the current state for the market. Analysis and discussion of important industry like market trends, size, share, growth estimates are mentioned in the report." Life Science Reagents Market Research has offered exhaustive analysis of Manufacturers, Suppliers, Regions, Type and Application, Forecast to 2027. And also provides essential study on the current status of the market, cover market size with respect to valuation as sales volume and providing a precise prediction of the market scenario over the forecast period from 2020 to 2027. Download Free Sample PDF@   https://www.alliedmarketresearch.com/request-sample/12658 The report provides revenue forecast with sales, sales growth rate, and revenue growth rate forecasts of the global    Life S

副鼻腔拡張デバイス市場 Expected to Reach $5,778 Million by 2023 - Allied Market Research

  Sinus Dilation Devices Market by Product and End User: Global Opportunity Analysis and Industry Forecast, 2017-2023 ," the global sinus dilation devices market was valued at   $3,326 million   in 2016, and is projected to reach   $5,778 million   at a CAGR of 8.1% from 2017 to 2023. Sinusitis is a medical condition wherein inflammation of sinus lining leads to a plugged nose, headache, poor sense of smell, sore throat, and cough. It is caused due to either ostial blockage, bacterial infections, viral infections, or a combination of these conditions. This leads to use of sinus dilation devices during surgical procedures to dilate the sinus openings of a patient's nose. Request for Sample Report at:   https://www.alliedmarketresearch.com/request-sample/2128 The major factors that drive the global sinus dilation devices market are increase in incidence of sinusitis, which may lead to higher sinus surgeries, high adoption of minimally invasive surgical procedures, and technologi